{
  "ticker": "JNJ",
  "target_date": "2025-06-24",
  "actual_date": "2025-06-24",
  "collected_at": "2025-12-08T11:55:49.768812",
  "price": {
    "open": 149.45,
    "high": 150.65,
    "low": 148.93,
    "close": 150.1278533935547,
    "volume": 9544200,
    "change_1d_pct": 0.57,
    "change_7d_pct": -2.85,
    "change_30d_pct": -0.47
  },
  "technicals": {
    "rsi_14": 43.51,
    "sma_20": 151.84,
    "sma_50": 151.11,
    "macd": -0.342,
    "macd_signal": 0.11,
    "macd_histogram": -0.452,
    "bb_upper": 155.82,
    "bb_lower": 147.86,
    "price_vs_sma20_pct": -1.13,
    "price_vs_sma50_pct": -0.65,
    "volume_ratio": 1.17
  },
  "fundamentals": {
    "market_cap": 488882110464,
    "pe_ratio": 19.58639,
    "forward_pe": 19.142923,
    "price_to_book": 6.158831,
    "price_to_sales": 5.3053436,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.36,
    "pct_from_52w_low": 44.24
  },
  "macro": {
    "spy": {
      "price": 605.1,
      "change_1d_pct": 1.1,
      "change_7d_pct": 1.94
    },
    "vix": {
      "level": 17.48,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.29
    },
    "dollar_index": {
      "level": 97.86
    },
    "gold": {
      "price": 3317.4
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "J&J (JNJ) Faces $8M Verdict Over Talc Case; Stock Still Gains 4.66% YTD",
      "source": "Yahoo",
      "datetime": 1750800117,
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 18, Dean Omar Branham Shirley, LLP, a Dallas, Texas-based law firm, announced an $8 million verdict against Johnson & Johnson in Suffolk County, Massachusetts. The verdict was a",
      "url": "https://finnhub.io/api/news?id=3c236856a0bd4eb8e2a159d5c2ce925f6711075a32831a75212d89fd7bd2629b"
    },
    {
      "headline": "MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal",
      "source": "Yahoo",
      "datetime": 1750782000,
      "summary": "Merck's Winrevair meets goal in a phase III study in newly diagnosed PAH patients, showing strong efficacy.",
      "url": "https://finnhub.io/api/news?id=ffef75392d5f3cc01f3cab272e4aac23f379d5a91e27ee6aae3a81202292688b"
    },
    {
      "headline": "Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?",
      "source": "Yahoo",
      "datetime": 1750775100,
      "summary": "PFE faces a decline in COVID revenues, LOE pressure and IRA impacts but rising EPS estimates offer a glimmer of resilience.",
      "url": "https://finnhub.io/api/news?id=5c4f7360a1b1e638f10f9ab708d3565e404a83552a33b49e9cbfe943a62a8e22"
    },
    {
      "headline": "5 Dividend Stocks Poised to Profit From the AI Efficiency Boom",
      "source": "Yahoo",
      "datetime": 1750766400,
      "summary": "Boring dividend stocks are becoming the smartest way to profit from AI's efficiency revolution.  Microsoft (NASDAQ: MSFT) is using AI-powered code-completion tools to help developers write code 55% faster.  Johnson & Johnson (NYSE: JNJ) is leveraging AI to accelerate drug-discovery timelines.",
      "url": "https://finnhub.io/api/news?id=9208af17d327883e3e55f6757f31a0e35f7824bcd4ddc2a2f47e8634612b63e6"
    },
    {
      "headline": "Johnson & Johnson: Undervalued Dividend King With 65% Upside Potential",
      "source": "SeekingAlpha",
      "datetime": 1750765775,
      "summary": "Johnson & Johnson offers stability with 62 years of dividend growth and a 3.44% yield. Click for why JNJ is undervalued and poised for potential 65% upside.",
      "url": "https://finnhub.io/api/news?id=ad8e98110d6e9178ba9b500d6bbbfb8869489d5d11417dbc8c3145bd3187c0d3"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760336.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000156/xslF345X05/wk-form4_1749760336.xml"
    },
    {
      "form": "4",
      "date": "2025-06-12",
      "description": "xslF345X05/wk-form4_1749760229.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000154/xslF345X05/wk-form4_1749760229.xml"
    },
    {
      "form": "8-K",
      "date": "2025-06-10",
      "description": "jnj-20250610.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000152/jnj-20250610.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-05-07",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000238/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-05-05",
      "description": "xslF345X05/wk-form4_1746479407.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000143/xslF345X05/wk-form4_1746479407.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}